DrugPatentWatch Report Store
Showing 421–432 of 905 results
- Excipient Business Development Opportunity Reports
MAGNESIUM CARBONATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
MAGNESIUM HYDROXIDE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
MAGNESIUM OXIDE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
MAGNESIUM STEARATE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
MALTITOL Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
MALTODEXTRIN Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
MANNITOL Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
MAVYRET (glecaprevir; pibrentasvir) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
MAYZENT (siponimod) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
MEDIUM-CHAIN TRIGLYCERIDES Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Excipient Business Development Opportunity Reports
MEGLUMINE Drug Excipient Business Development Opportunity Report, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
MEKINIST (trametinib dimethyl sulfoxide) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now
